Antineoplastic Combined Chemotherapy ProtocolsChemotherapy, AdjuvantCombined Modality TherapyAntineoplastic AgentsCisplatinCyclophosphamideTreatment OutcomeDoxorubicinNeoadjuvant TherapyDisease-Free SurvivalBreast NeoplasmsEtoposideSurvival AnalysisNeoplasm StagingPrognosisSurvival RateLung NeoplasmsDrug Administration ScheduleMethotrexateCarboplatinPaclitaxelInduction ChemotherapyVinblastineNeoplasm Recurrence, LocalTaxoidsNeoplasmsIfosfamideDrug Resistance, NeoplasmBleomycinFollow-Up StudiesDeoxycytidineOrganoplatinum CompoundsAntimetabolites, AntineoplasticAnthracyclinesAntineoplastic Agents, AlkylatingChemotherapy, Cancer, Regional PerfusionCytarabineTime FactorsSalvage TherapyCarcinoma, Non-Small-Cell LungOvarian NeoplasmsNeoplasm MetastasisProspective StudiesTesticular NeoplasmsVomitingNeutropeniaAdenocarcinomaTransplantation, AutologousLymphoma, Non-HodgkinNauseaAntineoplastic Agents, PhytogenicRadiotherapy, AdjuvantHodgkin DiseaseColorectal NeoplasmsRadiotherapyClinical Trials as TopicAntibiotics, AntineoplasticDacarbazineNeoplasms, Germ Cell and EmbryonalCarmustineKaplan-Meier EstimateLomustineGranulocyte Colony-Stimulating FactorCamptothecinBrain NeoplasmsPlatinum CompoundsQuality of LifeBone NeoplasmsRisk FactorsDrug TherapyRandomized Controlled Trials as TopicInfusions, Intra-ArterialOsteosarcomaMelphalanLeukopeniaRecurrenceAntiemeticsMitomycinPalliative CareLiver NeoplasmsTumor Markers, BiologicalThiotepaDose-Response Relationship, DrugHematopoietic Stem Cell TransplantationInfusions, IntravenousPeritoneal NeoplasmsStomach NeoplasmsMitoxantroneLymphatic MetastasisTegafurAntibodies, Monoclonal, HumanizedDisease ProgressionGerminomaRadiotherapy DosageCell Line, TumorMultivariate AnalysisDaunorubicinCarcinoma, Squamous CellCarcinomaPrecursor Cell Lymphoblastic Leukemia-Lymphoma